These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22984561)

  • 1. Apoptosis induced by knockdown of uPAR and MMP-9 is mediated by inactivation of EGFR/STAT3 signaling in medulloblastoma.
    Kotipatruni RR; Nalla AK; Asuthkar S; Gondi CS; Dinh DH; Rao JS
    PLoS One; 2012; 7(9):e44798. PubMed ID: 22984561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNA-mediated downregulation of MMP-9 and uPAR in combination with radiation induces G2/M cell-cycle arrest in Medulloblastoma.
    Nagaraju GP; Nalla AK; Gupta R; Mohanam S; Gujrati M; Dinh DH; Rao JS
    Mol Cancer Res; 2011 Jan; 9(1):51-66. PubMed ID: 21148633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of uPAR retards radiation-induced invasion and migration mediated by integrin β1/FAK signaling in medulloblastoma.
    Nalla AK; Asuthkar S; Bhoopathi P; Gujrati M; Dinh DH; Rao JS
    PLoS One; 2010 Sep; 5(9):e13006. PubMed ID: 20886051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous downregulation of uPAR and MMP-9 induces overexpression of the FADD-associated protein RIP and activates caspase 9-mediated apoptosis in gliomas.
    Gondi CS; Dinh DH; Gujrati M; Rao JS
    Int J Oncol; 2008 Oct; 33(4):783-90. PubMed ID: 18813792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase plasminogen activator receptor and/or matrix metalloproteinase-9 inhibition induces apoptosis signaling through lipid rafts in glioblastoma xenograft cells.
    Chetty C; Lakka SS; Bhoopathi P; Gondi CS; Veeravalli KK; Fassett D; Klopfenstein JD; Dinh DH; Gujrati M; Rao JS
    Mol Cancer Ther; 2010 Sep; 9(9):2605-17. PubMed ID: 20716639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.
    Tummalapalli P; Gondi CS; Dinh DH; Gujrati M; Rao JS
    Int J Oncol; 2007 Jul; 31(1):5-17. PubMed ID: 17549400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas.
    Lakka SS; Gondi CS; Dinh DH; Olivero WC; Gujrati M; Rao VH; Sioka C; Rao JS
    J Biol Chem; 2005 Jun; 280(23):21882-92. PubMed ID: 15824107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase-type plasminogen activator receptor (uPAR)-mediated regulation of WNT/β-catenin signaling is enhanced in irradiated medulloblastoma cells.
    Asuthkar S; Gondi CS; Nalla AK; Velpula KK; Gorantla B; Rao JS
    J Biol Chem; 2012 Jun; 287(24):20576-89. PubMed ID: 22511755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells.
    Gupta R; Chetty C; Bhoopathi P; Lakka S; Mohanam S; Rao JS; Dinh DE
    Int J Oncol; 2011 Mar; 38(3):733-44. PubMed ID: 21181094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of nitric oxide synthase in matrix metalloproteinase-9- and/or urokinase plasminogen activator receptor-mediated glioma cell migration.
    Zhuang T; Chelluboina B; Ponnala S; Velpula KK; Rehman AA; Chetty C; Zakharian E; Rao JS; Veeravalli KK
    BMC Cancer; 2013 Dec; 13():590. PubMed ID: 24325546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic role of p53 is suppressed by si-RNA bicistronic construct of uPA, uPAR and cathepsin-B in meningiomas both in vitro and in vivo.
    Gupta R; Rao Gogineni V; Nalla AK; Chetty C; Klopfenstein JD; Tsung AJ; Mohanam S; Rao JS
    Int J Oncol; 2011 Apr; 38(4):973-83. PubMed ID: 21290090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
    Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
    J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells.
    Nalla AK; Gorantla B; Gondi CS; Lakka SS; Rao JS
    Cancer Gene Ther; 2010 Sep; 17(9):599-613. PubMed ID: 20448670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth.
    Kunigal S; Lakka SS; Gondi CS; Estes N; Rao JS
    Int J Cancer; 2007 Nov; 121(10):2307-16. PubMed ID: 17657740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas.
    Malla R; Gopinath S; Alapati K; Gondi CS; Gujrati M; Dinh DH; Mohanam S; Rao JS
    PLoS One; 2010 Oct; 5(10):e13731. PubMed ID: 21060833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor.
    Raghu H; Gondi CS; Dinh DH; Gujrati M; Rao JS
    Mol Cancer; 2011 Oct; 10():130. PubMed ID: 22004682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice.
    Veeravalli KK; Chetty C; Ponnala S; Gondi CS; Lakka SS; Fassett D; Klopfenstein JD; Dinh DH; Gujrati M; Rao JS
    PLoS One; 2010 Jul; 5(7):e11583. PubMed ID: 20657647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. uPAR and cathepsin B inhibition enhanced radiation-induced apoptosis in gliomainitiating cells.
    Malla RR; Gopinath S; Alapati K; Gorantla B; Gondi CS; Rao JS
    Neuro Oncol; 2012 Jun; 14(6):745-60. PubMed ID: 22573309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
    Lakka SS; Gondi CS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Cancer Res; 2003 May; 63(10):2454-61. PubMed ID: 12750266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.